Haemonetics Corporation

NYSE: HAE · Real-Time Price · USD
52.68
0.35 (0.67%)
At close: Aug 15, 2025, 12:09 PM

Haemonetics Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 29, 2025 Mar 30, 2024 Apr 1, 2023 Apr 2, 2022 Apr 3, 2021
Net Income
167.68M 117.56M 115.4M 43.38M 79.47M
Depreciation & Amortization
115.59M 97.22M 93.31M 97.75M 84.29M
Stock-Based Compensation
29.64M 28.33M 25.58M 24.36M 25.52M
Other Working Capital
-44.21M -35.03M -20.65M -12.15M -8.47M
Other Non-Cash Items
-48.2M 24.39M 8.48M 16.95M -919K
Deferred Income Tax
-5.22M -11.04M 4.78M 5.01M -19.87M
Change in Working Capital
-101.96M -74.7M 25.5M -15.18M -59.68M
Operating Cash Flow
181.72M 181.75M 273.06M 172.26M 108.81M
Capital Expenditures
-39.28M -66.3M -110.19M -96.51M -37.04M
Cash Acquisitions
n/a -242.35M -2M 8.14M -390.22M
Purchase of Investments
n/a n/a -33.2M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-122.62M -13.74M 1.61M 2.02M 1.81M
Investing Cash Flow
-161.9M -322.39M -143.79M -86.34M -425.44M
Debt Repayment
447.31M 37.75M -9.63M -17.5M 418.13M
Common Stock Repurchased
-225M n/a -75M n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
108.82M -6.81M -15.74M -4.8M -50.67M
Financial Cash Flow
108.82M 38.16M -100.36M -15.75M 367.45M
Net Cash Flow
127.96M -105.67M 24.97M 67.19M 54.99M
Free Cash Flow
142.45M 115.45M 162.87M 75.75M 71.77M